Nicholas Hoffman & Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$26.7M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$24.9M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$12.9M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$11.7M |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$5.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85M |
| 2 |
Eli Lilly
LLY
|
+$1.49M |
| 3 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$711K |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$664K |
| 5 |
Texas Pacific Land
TPL
|
+$631K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.31% |
| 2 | Financials | 7.24% |
| 3 | Consumer Staples | 1.89% |
| 4 | Healthcare | 1.61% |
| 5 | Consumer Discretionary | 1.18% |
Similar funds
Nicholas Hoffman & Company's Q3 2024 Portfolio in Review
As of Q3 2024, Nicholas Hoffman & Company held 301 positions worth $2.37B, up 11% from $2.13B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Nicholas Hoffman & Company deployed $84.6M of net new capital in Q3 2024, opening 16 new positions and adding to 109 existing holdings. Its largest new stake was Zimmer Biomet: 9,844 shares worth $1.06M.
By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 7.8% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.85M trimmed.
- Nicholas Hoffman & Company's largest Q3 2024 buy was Zimmer Biomet: 9,844 shares worth $1.06M.
- Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q3 2024, an estimated $26.7M increase.
- Nicholas Hoffman & Company's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.85M.
- Nicholas Hoffman & Company fully exited Novo Nordisk in Q3 2024, selling an estimated $496K.
- Nicholas Hoffman & Company's ten largest holdings make up 75% of its $2.37B portfolio in Q3 2024.
- Nicholas Hoffman & Company opened 16 new positions and closed 10 in Q3 2024.
- Nicholas Hoffman & Company's portfolio value rose 11% quarter-over-quarter to $2.37B.
Based on Nicholas Hoffman & Company's 13F filing for Q3 2024, filed 25 Oct 2024.